Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avet-Loiseau

Showing results (11-20 of 381) with videos related to

Pageof 39
Sort By:
Leukemia|May 4, 2018
Front-line therapies for elderly patients with transplant-ineligible multiple myeloma and high-risk cytogenetics in the era of novel agentsHerve Avet-Loiseau, Thierry Facon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Genomics in multiple myelomaNikhil C Munshi, Hervé Avet-Loiseau
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Minimal Residual Disease Negativity Is a New End Point of Myeloma TherapyJean-Luc Harousseau, Herve Avet-Loiseau
Blood|March 1, 2024
Smoldering multiple myeloma: taking the narrow over the wide path?Herve Avet-Loiseau, Nizar J Bahlis
Blood|January 29, 2015
Genetics of multiple myeloma: another heterogeneity level?Jill Corre, Nikhil Munshi, Hervé Avet-Loiseau
Medical Oncology (Northwood, London, England)|February 21, 2013
8p21.3 deletion suggesting a probable role of TRAIL-R1 and TRAIL-R2 as candidate tumor suppressor genes in the pathogenesis of multiple myelomaA Gmidène, A Saad, H Avet-Loiseau
Medecine Sciences : M/S|December 5, 2017
[Circulating exosomal microRNA as biomarkers in mutiple myeloma]Salomon Manier, Xavier Leleu, Hervé Avet-Loiseau
Presse Medicale (Paris, France : 1983)|May 19, 2007
[Malignant transformation of monoclonal gammopathy of undetermined significance]Olivier Decaux, Hervé Avet-Loiseau, Bernard Grosbois
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Risk Stratification and Targets in Multiple Myeloma: From Genomics to the BedsideAurore Perrot, Jill Corre, Hervé Avet-Loiseau
JAMA Oncology|July 19, 2019
Monoclonal Gammopathy May Be of Unpredictable SignificanceNikhil C Munshi, Sundar Jagannath, Herve Avet-Loiseau
Pageof 39

Showing results (11-20 of 381) with videos related to

Sort By:
Pageof 39
Leukemia|May 4, 2018
Front-line therapies for elderly patients with transplant-ineligible multiple myeloma and high-risk cytogenetics in the era of novel agentsHerve Avet-Loiseau, Thierry Facon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Genomics in multiple myelomaNikhil C Munshi, Hervé Avet-Loiseau
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Minimal Residual Disease Negativity Is a New End Point of Myeloma TherapyJean-Luc Harousseau, Herve Avet-Loiseau
Blood|March 1, 2024
Smoldering multiple myeloma: taking the narrow over the wide path?Herve Avet-Loiseau, Nizar J Bahlis
Blood|January 29, 2015
Genetics of multiple myeloma: another heterogeneity level?Jill Corre, Nikhil Munshi, Hervé Avet-Loiseau
Medical Oncology (Northwood, London, England)|February 21, 2013
8p21.3 deletion suggesting a probable role of TRAIL-R1 and TRAIL-R2 as candidate tumor suppressor genes in the pathogenesis of multiple myelomaA Gmidène, A Saad, H Avet-Loiseau
Medecine Sciences : M/S|December 5, 2017
[Circulating exosomal microRNA as biomarkers in mutiple myeloma]Salomon Manier, Xavier Leleu, Hervé Avet-Loiseau
Presse Medicale (Paris, France : 1983)|May 19, 2007
[Malignant transformation of monoclonal gammopathy of undetermined significance]Olivier Decaux, Hervé Avet-Loiseau, Bernard Grosbois
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Risk Stratification and Targets in Multiple Myeloma: From Genomics to the BedsideAurore Perrot, Jill Corre, Hervé Avet-Loiseau
JAMA Oncology|July 19, 2019
Monoclonal Gammopathy May Be of Unpredictable SignificanceNikhil C Munshi, Sundar Jagannath, Herve Avet-Loiseau
Pageof 39